Stop Taxpayer-Funded Mobile Flu Vaccine Units!

🖨️ Print post

Members of Congress are considering legislation that would direct federal funding toward expanding mobile influenza vaccination units nationwide.

H.R. 7465, the “Fight Flu Act,” would authorize taxpayer dollars to support mobile vaccine clinics designed to increase influenza vaccination rates, particularly in underserved communities.

While access to healthcare is important, this bill expands federal involvement in vaccine promotion and delivery without addressing informed consent, liability protections, long-term safety concerns, or individualized risk assessment. It further entrenches a one-size-fits-all public health model driven by federal funding incentives rather than patient-centered care.

Public health policy should prioritize transparency, voluntary participation, and respect for bodily autonomy — not federally funded outreach campaigns that normalize pharmaceutical intervention as the primary solution.

Please act TODAY!

TAKE ACTION

Contact your U.S. Representative and ask them to OPPOSE H.R. 7465.

Find your Representative here:
 https://www.house.gov/representatives/find-your-representative

Phone calls are most effective, but emails help too.

SAMPLE SCRIPT

“Hello, my name is ___ and I’m a constituent. I’m calling to urge Representative ___ to OPPOSE H.R. 7465.

This bill expands federal funding for mobile flu vaccination units without addressing informed consent, liability protections, or individualized medical decision-making.

Medical interventions should remain voluntary and based on a personal risk assessment between a patient and their healthcare provider — not driven by federally funded outreach programs.

Please oppose H.R. 7465 and protect medical freedom and responsible use of taxpayer dollars.

Thank you.”

TALKING POINTS

1. According to the CDC, flu vaccines provide limited protection. Effectiveness varies widely from season to season and frequently offers only a modest reduction in risk, with no guarantee of preventing infection or transmission.

2. Flu shots carry known risks and include concerning ingredients. Formulations may contain adjuvants, preservatives, antibiotics, and residual manufacturing materials that can trigger allergic, neurological, or immune reactions in susceptible individuals.

3. Influenza vaccines account for a significant share of compensated vaccine injuries. Claims involving flu shot injuries and deaths represent a substantial portion of cases paid through the federal Vaccine Injury Compensation Program.

4. Safety data for certain populations remains debated. Recommendations for groups such as pregnant women and the elderly have expanded over time, despite ongoing questions about the strength and quality of long-term safety data.

5. Mobile vaccination programs may weaken informed consent. High-volume, outreach-based models risk minimizing individualized risk assessment and full disclosure of benefits, limitations, and alternatives.

6. Manufacturers are largely shielded from liability. Federal law limits the ability of injured individuals to sue vaccine makers, reducing direct accountability for adverse outcomes.

7. H.R. 7465 expands centralized federal vaccine infrastructure. Increasing taxpayer-funded mobile vaccine units shifts healthcare delivery toward federally coordinated pharmaceutical campaigns rather than local, patient-centered care.

8. Permanent federal delivery systems can outlast their original purpose. Expanding national vaccine infrastructure for seasonal flu establishes a framework that could later be used for broader vaccination efforts or emergency programs beyond influenza.

MORE INFORMATION

H.R. 7465 — Bill text and status:
 https://www.congress.gov/bill/119th-congress/house-bill/7465/text For additional information on flu vaccines, read this article: https://www.westonaprice.org/health-topics/the-flu-shot-unsafe-ineffective-and-not-necessary/

🖨️ Print post